Technology | June 06, 2010

Biocompatible Gold Markers Track Tumors for IGRT

June 7, 2010 - One of the biggest challenges in image-guided treatments is tissue location. To help guide visibility, new biocompatible pure gold implanted markers are designed to identify the location of normal or diseased tissue for future treatments, including image-guided radiation therapy (IGRT).

The markers, FlexiMarc and FlexiCoil, used primarily for IGRT, are the first implanted fiducials designed with image projection and marker stability as the primary objectives. Unique node-based technology projects a non-biological image providing the best reference for accurate localization. Both the human eye and software programs can identify FlexiMarc and FlexiCoil.

FlexiMarc’s clearly definable nodes and endpoints project a non-biological image for better automated registration or point based localization. FlexiMarc is available in two or three node variations; nodes are fixed 10 mm apart, are 3 mm long and are available in 0.9 and 1.2 mm diameters.

FlexiCoil was designed with the same imaging advantages as FlexiMarc, but the nodes are placed inside a pure gold coil. FlexiCoil is constructed of a flexible pure gold coil, and is available in 10 and 20 mm lengths. 30 mm lengths will be available shortly. FlexiCoils are currently available with 0.9 and 1.2 mm diameters, and smaller diameter markers are in development. Nodes are placed at each end of the coil, making it simple to locate and determine the exact end of the line.

For more information:

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init